等待开盘 08-06 09:30:00 美东时间
-0.080
-0.20%
今日重点评级关注:巴克莱:维持Snap"超配"评级,目标价从15美元升至16美元;Canaccord Genuity:维持阿梅雷斯克"买入"评级,目标价从59美元升至62美元
08-05 11:45
JP Morgan analyst Brian Cheng maintains Immunovant (NASDAQ:IMVT) with a Overweight and raises the price target from $47 to $50.
08-05 02:40
Insiders have been trading these 5 stocks: (($IMVT)), (($HP)), (($SN)), (($PBF)...
07-25 21:01
Immunovant, Inc. announced it will report its Q1 2026 financial results on August 6, 2026 before the market opens. Roivant Sciences Ltd., Immunovant's majority stockholder, will host a live conference call and webcast at 8:00 a.m. ET that day, including a business update for Immunovant. Registration links and details are available on the Immunovant website.
07-23 20:05
Insiders have been trading these 5 stocks: (($LRMR)), (($CYTK)), (($ITUB)), (($...
07-11 21:01
今日重点评级关注:Citizens:维持DBV Technologies"跑赢大市"评级,目标价从47美元升至55美元;康托·菲茨杰拉德:维持BioCryst制药"超配"评级,目标价从27美元升至29美元
07-01 10:40
Citigroup analyst Samantha Semenkow maintains Immunovant (NASDAQ:IMVT) with a Buy and raises the price target from $57 to $61.
07-01 02:49
今日重点评级关注:Canaccord Genuity:维持Dakota Gold"投机性买入"评级,目标价从16美元升至18美元;瑞杰金融:上调Tectonic Therapeutic评级至"强烈买入",目标价从76美元升至81美元
05-27 17:33
今日重点评级关注:康托·菲茨杰拉德:维持Ultragenyx药业"超配"评级,目标价从84美元升至96美元;Ascendiant Capital:维持Liqtech国际"买入"评级,目标价从4.3美元升至4.4美元
05-22 10:18